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Long-Range Control of Gene Expression: Emerging Mechanisms
and Disruption in Disease
Dirk A. Kleinjan and Veronica van Heyningen
MRC Human Genetics Unit, Western General Hospital, Edinburgh
Transcriptional control is a major mechanism for regulating gene expression. The complex machinery required to
effect this control is still emerging from functional and evolutionary analysis of genomic architecture. In addition
to the promoter, many other regulatory elements are required for spatiotemporally and quantitatively correct gene
expression. Enhancer and repressor elements may reside in introns or up- and downstream of the transcription
unit. For some genes with highly complex expression patterns—often those that function as key developmental
control genes—the cis-regulatory domain can extend long distances outside the transcription unit. Some of the
earliest hints of this came from disease-associated chromosomal breaks positioned well outside the relevant gene.
With the availability of wide-ranging genome sequence comparisons, strong conservation of many noncoding regions
became obvious. Functional studies have shown many of these conserved sites to be transcriptional regulatory
elements that sometimes reside inside unrelated neighboring genes. Such sequence-conserved elements generally
harbor sites for tissue-specific DNA-binding proteins. Developmentally variable chromatin conformation can control
protein access to these sites and can regulate transcription. Disruption of these finely tuned mechanisms can cause
disease. Some regulatory element mutations will be associated with phenotypes distinct from any identified for
coding-region mutations.
Introduction
Thanks to the completion of the annotated human se-
quence and to the huge progress in many other genome
programs, 11,500 genes have been linked with specific
clinical phenotypes (Valle 2004). In most reported cases,
disease-associated mutations alter the protein coding se-
quence of the gene in some way. However, there are
potentially many different mechanisms that can disrupt
normal gene function and can lead to pathological states.
Growing insight into genomic organization (Gaffney and
Keightley 2004) and into the multiple levels of tran-
scriptional regulation (Levine and Tjian 2003) have re-
vealed ways in which gene function may be disturbed.
In addition, heroic detective work to understand some
unusual human disease mutations has uncovered novel
insights into the mechanisms of gene regulation.
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Functional Gene Domains Extend beyond the
Transcription Unit
The majority of protein-coding genes are organized
into multiple exons, which must be spliced to produce
the mRNA that is translated into protein (fig. 1). A 5′
promoter element, contiguous with the transcription
start site (the minimal or core promoter), is required to
assemble the protein complex necessary for RNA syn-
thesis (Levine and Tjian 2003). For many genes, the
region immediately upstream of the minimal promoter
contains sufficient transcription factor binding sites to
direct correct expression of the gene—these are termed
“regulatory promoters.” However, many genes also re-
quire multiple cis-acting distant genomic elements for
spatiotemporally correct expression (Howard and Da-
vidson 2004). These are often defined as enhancers, al-
though some will be repressors or insulators; they can
be located upstream, within introns, or downstream of
the “transcription unit,” which comprises the tran-
scribed exons and introns from the promoter to the poly-
adenylation site (fig. 1). Additional complexities include
the possible presence of multiple alternative promoters
and exons. The genomic regions harboring regulatory
elements can stretch as much as 1 Mb in either direction
from the transcription unit (Pfeifer et al. 1999; Kimura-
Yoshida et al. 2004). Some or all of these elements may
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Figure 1 Schematic representation of a theoretical gene locus, highlighting various cis elements that contribute to the regulation of gene
expression. Exons are indicated by rectangular boxes, with the protein-coding portions in black. Complexity of gene output can be achieved
through use of alternative promoters and/or exons. Multiple cis-regulatory elements, indicated by ovals, control the quantitative and spatio-
temporal specific expression. These elements may be at considerable distances from the promoter, either upstream or downstream, and are
sometimes within or beyond an adjacent gene. The chromatin structure of the locus is determined by a combination of the activities of these
cis elements and the wider chromosomal and nuclear environment. In some loci, the outermost cis elements may carry some boundary activity,
isolating the specific chromatin structure of the gene domain from that of adjacent chromosomal segments.
reside within the introns of neighboring gene(s), often
with function unrelated to the regulated gene (Kleinjan
et al. 2001; Lettice et al. 2002).
Cis-acting regulators can only fulfill their role if the
chromatin structure in the region is appropriate. Some of
the cis elements contribute to the organization of that
structure. Chromatin exists in what is probably a struc-
tural continuum between the closed heterochromatic and
open euchromatic state. Constitutive heterochromatin is
found at centromeres and telomeres and in regions con-
taining repetitive DNA. Facultative heterochromatin rep-
resents transiently silenced euchromatin. For high-level
transcription, chromatin needs to be in an open (euchro-
matic) conformation (Elgin and Grewal 2003; Vermaak
et al. 2003). A great deal of work is emerging that defines
the machinery required for modulation of chromatin or-
ganization, with many protein components—and, re-
cently, RNA components—still being identified (Elgin and
Grewal 2003; Grewal and Rice 2004; Schramke and All-
shire 2004). As with transcription factors, both general
and tissue-specific components are required for this pro-
cess. Many factors that affect chromatin and histone
structure have been identified as regulating transcriptional
control through acetylation, methylation, and ubiquitin-
ation of histone tails (Cho et al. 2004; Egger et al. 2004).
The combination of specific histone modifications at a
locus is usually referred to as the “histone code” (Turner
2002). Little is known about the factors that determine
higher-order chromatin structure, such as the formation
of hetero- and euchromatin.
Chromosomal Rearrangements Can Lead to Aberrant
Gene Transcription through Different Mechanisms
Transcriptional control can be disrupted by one or both
of the following mechanisms: (1) disturbing the interac-
tions of the promoter and transcription unit with its cis-
acting regulators, either by mutation or by physical dis-
sociation of the transcribed gene from its full set of
regulators (examples below and in table 1); and/or (2)
alteration of local or global regulation of chromatin struc-
ture (Kleinjan and van Heyningen 1998; Jiang et al. 2003;
Saveliev et al. 2003; Tufarelli et al. 2003). Chromosomal
rearrangements can act through both these mechanisms.
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Because they are readily visualized through cytogenetic
analysis, they were the first to be implicated in Drosophila
position-effect variegation (PEV), in which mosaic pat-
terns of gene expression were observed when genes that
normally resided in euchromatic domains were trans-
posed close to a heterochromatic region (Wallrath and
Elgin 1995). Subsequently, germline chromosomal re-
arrangements were identified in some human diseases in
which the implicated gene had already been firmly estab-
lished but the phenotype-associated breakpoints were
found to lie significantly outside the transcription unit.
By analogy with Drosophila PEV mutations, such extra-
genic rearrangements were initially described as “position
effects.” In recent years, an increasing number of such
disease-related position-effect cases have come to light and
are reviewed here. Extensive study of some of these cases
has highlighted the importance of long-range transcrip-
tional control in the affected genes, and, in some cases,
such study has been instrumental in identifying distant
cis-regulatory elements. In most cases, the genetic defect
can be explained as a disruption of normal cis regulation
of transcription, without clear evidence of altered chro-
matin organization, although mechanisms are difficult to
assess in human disease, in which access to the affected
tissues is often impossible. No variegation effects have
been reported in humans, although the phenomenon has
been observed in transgenic mice in which incomplete
functional gene domains became inserted into hetero-
chromatic genomic regions (Milot et al. 1996; Festenstein
et al. 1999). Nonetheless, there are human disease states
for which altered chromatin states, associated with chro-
mosomal rearrangement, are implicated in the patholog-
ical mechanism (e.g., facioscapulohumeral dystrophy
[FSHD] [see below]). Malignancy-associated somatic
changes associated with altered chromatin conformation
are not discussed here.
Phenotypes Associated with Regulatory Mutants
In humans, disturbance of long-range control by chro-
mosomal rearrangement or deletion is most readily iden-
tified when the phenotype is a loss-of-function change
very similar to those caused by point mutations within
the coding region of the gene. However, it is important
to realize that sequence changes (mutations) or localized
deletion of specific elements may also to lead to novel
phenotypes through partial, tissue-specific loss or gain of
expression. Some examples have been identified, initially
through mouse models (Lettice et al. 2003) or through
detailed mapping and sequencing studies around a strong
candidate gene (Enattah et al. 2002). Validation for the
unpredictable effects of noncoding-region variation is
now emerging (Knight 2003).
Disturbance of Long-Range Regulation at Human
Disease Loci
Aniridia and PAX6: The Essential Role of a 200-kb
Downstream Regulatory Domain
Aniridia (absence of the iris [MIM 106210]) and related
eye anomalies are caused mainly by haploinsufficiency of
the paired box/homeodomain gene, PAX6, at chromo-
some 11p13 (van Heyningen and Williamson 2002). A
good model is provided by the Small eye (Sey) mouse
(Hill et al. 1991). A number of aniridia cases have been
described with no identifiable mutation in the transcrip-
tion unit. Instead, chromosomal rearrangements disrupt
the region downstream of the PAX6 transcription unit
(Fantes et al. 1995; Lauderdale et al. 2000; Kleinjan et
al. 2001; Crolla and van Heyningen 2002) (fig. 2A). De-
tailed mapping of the breakpoints placed them down-
stream of PAX6, with the furthest located 125 kb beyond
the final exon (Fantes et al. 1995; Kleinjan et al. 2001,
2002). In silico transcript analysis of this region revealed
the presence of a ubiquitously expressed neighboring
gene, ELP4, which encodes a transcriptional elongation
protein that is transcribed from the opposite strand (i.e.,
tail-to-tail with PAX6). All the human aniridia break-
points map within the large (1100 kb) final intron of
ELP4, presumably disrupting function of that allele, but
transgenic YAC rescue of a mouse Sey deletion mutant
showed that haploinsufficiency for Elp4 does not con-
tribute to the eye phenotype (Kleinjan et al. 2002). Com-
plete rescue of the heterozygous eye phenotype—and of
the homozygous lethality, caused by a mouse Pax6 null
mutation—is achieved with a 420-kb human YAC ending
at YA (but not with one 80 kb shorter, ending at YB [fig.
2A]) (Schedl et al. 1996; Kleinjan et al. 2001). Essential
regulatory elements were identified in Pax6-expressing
cells between YA and YB by the presence of DNase I
hypersensitive sites (HSs)—regions of chromatin open for
regulatory factor binding. Transgenic reporter studies in
mice revealed tissue-specific enhancer function for several
of these elements (Kleinjan et al. 2001; Griffin et al. 2002).
The cis-regulatory role of the distant elements was neatly
illustrated in mouse-human somatic cell hybrids capable
of expressing Pax6, in which human PAX6 was only ex-
pressed when a normal human chromosome 11 was re-
tained, but not when harboring patient chromosomes
with the PAX6 transcription unit intact but with distant
downstream regulatory elements deleted (Lauderdale et
al. 2000).
TWIST, POU3F4, PITX2, and GLI3
A number of developmental regulators with well-es-
tablished haploinsufficiency phenotypes have been doc-
umented to give rise to similar loss-of-function pheno-
types through disruption of long-range control: TWIST,
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Figure 2 Details of position-effect cases caused by disruption of long-range gene control. In all cases, the affected gene(s) are shown in
red, and other genes are shown in purple or blue. Filled boxes indicate individual exons, and hashed boxes represent full genes. L-shaped black
arrows indicate the direction of transcription. A, Human PAX6 locus. The loss of a set of DNase I HSs downstream from one allele causes
aniridia. The HSs are located within introns of the adjacent ubiquitously expressed ELP4 gene. Some documented aniridia-associatedbreakpoints
are denoted by blue arrows. The downstream end of the correcting YAC transgene (YA) and the noncorrecting one (YB) are shown in green.
Both upstream YAC ends are ∼200 kb 5′ of the PAX6 promoters. Isolated HSs have been shown to act as tissue-specific enhancers for lens and
retinal expression. B, The human POU3F4 deafness locus. The microdeletion of an 8-kb region located 900 kb upstream of the gene contains
a conserved noncoding sequence, the loss of which leads to congenital deafness. The mouse slf inversion breakpoint X leaves the neural tube
enhancer (nt) intact. C, Mouse/human upstream SHH region. A complex hotspot for limb abnormalities is found 1 Mb upstream of SHH,
within the introns of LMBR1. The region contains a conserved noncoding element that is capable of functioning as an enhancer that drives
SHH expression in the limb bud in both an anterior and posterior zone, as well as a repressor element that silences the anterior expression.
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The Sasquatch insertion disrupts the anterior repression function, whereas the acheiropodia deletion is thought to disrupt positive enhancer
activity. D, Human FSHD region. Deletion of an integral number of D4Z4 repeats from the tip of the long arm of chromosome 4 to below a
threshold of 10 repeats results in FSHD. A contentious model suggests that a multiprotein repressor complex fails to bind adequately to the
deleted allele, which leads to derepression of several genes in the region proximal to the repeat array and causes the phenotype. E, Human a-
globin locus (HBA). Deletion of the polyadenylation signal from the ubiquitously expressed LUC7L gene on the opposite strand leads to
transcription of an antisense RNA that runs through the HBA2 gene, resulting in silencing and methylation of the HBA2 promoter. Open ovals
indicate unmethylated CpG islands; the gray oval depicts the methylated CpG island. F, Mouse Hoxd cluster. A GCR regulates expression of
multiple consecutive Hoxd genes in a tissue-specific manner. In the distal limb, the GCR also regulates the expression of Lnp, Evx2, and
Hoxd13–10, whereas in the CNS it controls Lnp and Evx2. G, Mouse IL4/IL13 region. A conserved noncoding element (CNE) located between
IL4 and IL13 controls expression of both genes, as well as IL5, but does not influence expression of the KIF3a and RAD50 genes. H, Human
b-globin locus (HBB). Deletion of a large genomic region upstream of the human b-globin genes, including the LCR, results in reduced DNase
I sensitivity and histone acetylation levels across the locus, which causes loss of globin expression. The b-globin locus is embedded within a
region that contains numerous OR genes.
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a bHLH transcription factor; POU3F4 (previously,Brn4),
with a POU domain and homeobox; PITX2, a paired-
type homeodomain gene; and GLI3, a zinc finger gene
homologous to Drosophila, cubitus interruptus (ci),
which is a DNA-binding component of the sonic hedge-
hog signaling pathway. Loss-of-function mutations in
TWIST lead to Saethre-Chotzen syndrome, an autosomal
dominant form of craniosynostosis (Chun et al. 2002).
By use of real-time PCR to analyze the allele dosage by
“walking” across the critical region, translocation or in-
version breakpoints, located at least 260 kb downstream
of the TWIST gene, were found in two patients, which
is suggestive of long-range disruption of gene function
(Cai et al. 2003).
The POU3F4 gene (fig. 2B) is involved in the patho-
genesis of the most common form of X-linked deafness,
deafness type 3 (MIM 304400). Clinical features include
fixation of the stapes and a widening of the internal au-
ditory canal, which allows entry of cerebrospinal fluid
into the inner ear. In addition to a spectrum of missense
and truncating mutations, a complex duplication/inver-
sion case involving distant upstream regions of POU3F4,
as well as several genomic deletion cases, suggested up-
stream cis control of the gene (de Kok et al. 1995). The
deletions observed in multiple independent patient cases
overlap in a small region ∼900 kb upstream of the gene
(de Kok et al. 1996). The smallest of these deletions com-
prises an 8-kb fragment containing a 2-kb sequence that
is 80% conserved between mouse and human (Cremers
and Cremers 2004). In addition, the mouse mutant sex-
linked fidget (slf), generated in a random mutagenesis
screen, was found to have developmental malformations
of the inner ear that result in hearing loss and vestibular
dysfunction and was defined by molecular analysis to re-
sult from a regulatory mutation of Pou3f4/Brn4 (Phip-
pard et al. 2000). A large X-linked inversion was iden-
tified, with one breakpoint (“X” in fig. 2B) near, but not
in, the Pou3f4 transcription unit. Expression in the em-
bryonic inner ear, but not in the neural tube, was abol-
ished, as two neural tube enhancers (“nt” in fig. 2B)
within 6 kb of the promoter (Heydemann et al. 2001)
were not disrupted.
Rieger syndrome type 1 (MIM 180500) is an auto-
somal dominant disorder characterized by dental hy-
poplasia and malformation of the umbilicus and ante-
rior segment of the eye. The locus maps to 4q25, and
mutations in PITX2, a paired-related bicoid-type hom-
eobox gene encoding multiple isoforms, have been iden-
tified in individuals with Rieger syndrome (Alward et al.
1998). In addition to deletions and mutations in the gene
itself, a translocation breakpoint 90 kb upstream of the
gene was found in one patient (Flomen et al. 1998). Two
further translocation breakpoints mapping 15–90 kb up-
stream of PITX2 have recently been identified (Trembath
et al. 2004). The presence of a complex regulatory region
around PITX2 is not surprising in light of its complex
expression pattern, fulfilling diverse roles throughout de-
velopment, not just in the eye but also in tooth, pituitary,
heart, and laterality determination.
The zinc finger gene GLI3 on chromosome 7p13 is
involved in the embryonal development of the brain, the
limbs, and the skull and is an important effector of the
hedgehog signaling network. Greig cephalopolysyndac-
tyly syndrome (MIM 175700) is caused by haploinsuf-
ficiency of GLI3 on 7p13 (Wild et al. 1997). A probable
position effect that results from a translocation has been
described in a patient with a breakpoint 10 kb down-
stream from the last exon of GLI3 (Wild et al. 1997).
Two dominant Gli3 mutant alleles in the mouse, the extra
toes (Xt and XtJ) phenotypes, are caused by mutations in
Gli3 itself (Vortkamp et al. 1992). The weak recessive Xt
allele, anterior digit deformity (add), is caused by a trans-
gene integration, combined with the deletion of an 80-kb
region ∼40 kb upstream of Gli3 (van der Hoeven et al.
1993).
Lens Developmental Regulator MAF
Awareness of the possibility of long-range effects, cou-
pled with biological insight into what makes a good can-
didate gene, can alert us to question whether an observed
translocation is exerting its effect by haploinsufficiency of
the disrupted gene. The chromosomal rearrangement,
which apparently affects one gene, may, in fact, dissociate
remote control elements from a more meaningful candi-
date gene located some distance away. Breakpoint analysis
of a t(5;16) translocation in a family with cataracts and
ocular anterior segment anomalies indicated that the
translocation occurred in an intron of the WWOX gene,
within a common fragile-site region on chromosome 16
(Paige et al. 2000). However, since WWOX is a widely
expressed putative tumor suppressor gene and since the
phenotype was observed in both balanced and unbal-
anced forms of the translocation, WWOX seemed an un-
likely candidate to cause an eye phenotype. On the basis
of its expression pattern and known involvement in eye
development, misregulation of the bZIP transcription fac-
tor gene MAF (v-maf musculoaponeurotic fibrosarcoma
oncogene homolog [avian]), located ∼1 Mb telomeric of
the breakpoint, was considered a more likely candidate.
Subsequent identification of a MAF (MIM 177075) mis-
sense mutation in another family with lens and iris anom-
alies confirmed the role of MAF in lens development (Ja-
mieson et al. 2002). The observation that balanced and
unbalanced forms of the t(5,16) translocation give rise to
similar phenotypes suggests that the translocation leads
to dominant misregulation of MAF, perhaps through se-
quences on the der(5) chromosome. Identification of a
novel Maf missense mutation in the Ofl (opaque flecks in
lens) mouse mutant confirms the dominant phenotype
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hypothesis for the missense mutation, since heterozygous
Maf-null mice have no phenotype, and it provides a model
for exploring Maf gene function in more detail (Lyon et
al. 2003).
Forkhead Genes and Eye Development
A number of long-range regulatory disruptions are
associated with genes of the forkhead/winged helix
group of transcription factors, indicating the complex
regulatory requirements of this gene family. Forkhead
genes are involved in a diverse range of developmen-
tal pathways, with a significant number involved in eye
development (Lehmann et al. 2003). FOXC1 (previous-
ly, FKHL7) lies in a cluster of forkhead genes on chro-
mosome 6p25. Mutations cause ocular malformations
with iris hypoplasia and glaucoma (iridogoniodysgene-
sis type 1 [IRID1] [MIM 601631]). The phenotypes are
very similar, whether a segment is duplicated or delet-
ed, which suggests that precise gene dosage is critical for
normal eye development (Nishimura et al. 2001; Leh-
mann et al. 2003). In addition to intragenic point mu-
tations and dosage effects for the FOXC1 gene in in-
dividuals with IRID1, a balanced translocation that
mapped 25 kb from the gene was found in a case with
primary congenital glaucoma (Nishimura et al. 1998).
A further patient, with glaucoma and autosomal dom-
inant iris anomaly, was shown to carry an interstitial
deletion of 6p24-p25, where the proximal breakpoint
was estimated to lie 1,200 kb from the FOXC1 locus
(Davies et al. 1999). Despite the large distance, this pa-
tient could well represent another FOXC1 position-ef-
fect case. However, the situation is not clear-cut, because
other possible candidate genes, notably the transcription
factor TFAP2A, are located in the deletion interval.
A closely related forkhead gene, FOXC2, maps to
chromosome 16q24 (Fang et al. 2000). Inactivating mu-
tations have been identified in patients with lymphedema
distichiasis (LD [MIM 153400]), an autosomal domi-
nant disorder characterized by lymphedema that affects
the limbs and by double rows of eyelashes (distichiasis).
Other complications may include cardiac defects, cleft
palate, extradural cysts, and photophobia, which high-
light the pleiotropic functions of FOXC2 during devel-
opment. A translocation t(Y;16)(q12;q24.3) with the
breakpoint mapping ∼120 kb 3′ of the FOXC2 gene was
reported in a patient with neonatal lymphedema. The
translocation did not appear to interrupt a gene on chro-
mosome 16, nor were any candidate genes found on the
Y chromosome. This made a clear case for a position
effect on FOXC2, once multiple inactivating mutations
had been identified in other individuals with this phe-
notype. Interestingly, another forkhead gene, FOXL1,
also maps between FOXC2 and the breakpoint and thus
could also be inactivated and have phenotypic effects in
the translocation patient (Fang et al. 2000). Because
many intragenic FOXC2 mutations have been docu-
mented in LD individuals (Finegold et al. 2001; Brice et
al. 2002), disruption of FOXC2 and not FOXL1 is as-
cribed to this chromosomal rearrangement.
FOXL2 is the forkhead family member in which trans-
location breakpoints some distance upstream of the gene
cause phenotypes indistinguishable from loss-of-function
mutations within that gene. Coding-region mutations in
FOXL2 lead to blepharophimosis-ptosis-epicanthus in-
versus syndrome (MIM 110100), an eyelid and forehead
dysmorphology in both sexes that is often associated with
gonadal dysgenesis and premature ovarian failure in
women (Crisponi et al. 2001). The breakpoints all map
∼170 kb 5′ of FOXL2, in intron 6 of the ubiquitously
expressed MRPS22 gene (De Baere et al. 2001, 2003;
Crisponi et al. 2004). Sequence comparisons between hu-
man and mouse reveal the presence of three highly con-
served segments beyond the furthest breakpoint, in in-
trons 6, 11, and 12 of MRPS22. Interestingly, polled
intersex syndrome is a genetic syndrome in goats that
combines a craniofacial defect resulting in polledness (ab-
sence of horns), female infertility, and XX sex reversal. It
is caused by an 11.7-kb deletion in the homologous
FOXL2 region of the goat genome, encompassing the
conserved sequence in intron 11 of MRPS22 (Pailhoux
et al. 2001). These elements are strong candidates to func-
tion as distant cis-regulatory elements affecting FOXL2
expression.
SOX9 Campomelic Dysplasia (CD) and Sex
Determination
The HMG box gene SOX9 was identified as the gene
responsible for autosomal sex reversal and CD (MIM
114290); coding-region mutations for this gene have been
defined, and a high frequency of chromosomal trans-
locations that do not disrupt the transcribed gene have
been detected (Foster et al. 1994; Wagner et al. 1994).
SOX9 is therefore one of the oldest examples of a human
gene in which long-range regulation has been implicated
and studied. The phenotypes observed are variable but
generally severe, so that vertical transmission of mutations
is rarely observed. In addition to the variable osteochon-
drodysplasia, XY sex reversal is found in about two-thirds
of karyotypic male cases. All the rearrangements are
found from 50 kb to 950 kb upstream of SOX9 (Pfeifer
et al. 1999). The phenotypes of the breakpoint cases are
generally similar to, although less severe than, the loss-
of-function intragenic mutations. This, combined with the
absence of any validated ORFs in the 1-Mb region up-
stream, suggests that the chromosomal rearrangements
remove one or more cis-regulatory elements.
As in other cases, the availability of mouse models and
comparative sequence analysis has aided the dissection of
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regulatory function in the SOX9 region. Heterozygous
knockout of Sox9 in the mouse recapitulates the CD phe-
notype, except for the sex reversal (Kist et al. 2002). The
involvement of long-range gene control is supported by
the fact that mice transgenic for human SOX9-spanning
YACs showed transgene expression patterns similar to
those in endogenous Sox9 (except in gonads), but only
when the YAC transgene contained a 350-kb sequence
upstream of SOX9 and not with a truncated YAC that
contained only 75 kb of 5′ flanking sequence (Wunderle
et al. 1998). Comparative sequence analysis between hu-
man and Fugu rubripes revealed five conserved elements,
E1–E5, in the 290-kb region 5′ of human SOX9 and three
further elements, E6–E8, 3′ of SOX9 (Bagheri-Fam et al.
2001). On the basis of the expression pattern in the YAC
transgenics, elements E3–E5 are candidate enhancers for
SOX9 expression in limb and vertebral column. Of 10
CD translocation breakpoints analyzed so far, 8 separate
these elements from SOX9, with 2 other breakpoint cases
that suggest additional, more-distal enhancers (Pop et al.
2004).
A dominant insertional mutation in the mouse, named
“Odsex” (Ods [ocular degeneration with sex reversal]),
has been shown to dysregulate Sox9 expression. In a
transgenic experiment, a tyrosinase minigene driven by
the dopachrome tautomerase (Dct) promoter was ran-
domly inserted ∼1 Mb upstream of Sox9, additionally
causing a 134-kb deletion around the insertion site. In
contrast to the male-to-female sex reversal associated
with human SOX9 loss-of-function changes, Ods mice
show female-to-male sex reversal, as well as micro-
phthalmia with pigmentation defects and cataracts. The
XX sex-reversal phenotype is accompanied by misex-
pression of Sox9 in the XX gonad, where Sox9 is usually
repressed. Initially, it was proposed that the Ods deletion
had removed gonad-specific long-range regulatory ele-
ment(s) that would normally mediate the female-specific
repression of Sox9, thus resulting in up-regulation of
Sox9 and the consequent male development (Bishop et
al. 2000). However, more-recent experiments have shown
that the 134-kb deletion alone is insufficient to cause the
sex reversal (Qin et al. 2004). A double-gene–targeting
strategy was used to recreate the Ods insertional deletion
and the tyrosinase insertion—but this time driven by its
own promoter—no eye or sex-reversal phenotype was
observed. This suggests that long-range interaction occurs
specifically between the Dct promoter and Sox9 in the
Ods mutant. Indeed, the Ods eye phenotype was reca-
pitulated in transgenic mice with a Dct-Sox9 minigene
cassette, and a temporal misexpression of Sox9 under the
control of the Dct promoter was demonstrated. In the
eyes of Ods mice, the inserted Dct “promoter” element
seems to act as a long-range activator of the Sox9 pro-
moter over a distance of 980 kb. The mechanism behind
the sex-reversal phenotype is more complex. No sex re-
versal was seen in Dct-Sox9 transgenics, which suggests
that, in the gonads of Ods mice, the Dct promoter inter-
acts with Sox9 by an indirect mechanism, possibly in-
volving endogenous gonad-specific Sox9 enhancers and
chromosomal conformation changes as a result of the
deletion (Qin et al. 2004). Furthermore, the XX sex-re-
versal phenotype, driven by the original Ods transgene,
is highly background dependent, and a strong modifier
locus has been identified (Qin et al. 2003).
Holoprosencephaly (HPE) Is Associated with Long-
Range Regulator Effects for SIX3 and SHH
HPE is a complex brain malformation that results from
incomplete cleavage of the prosencephalon and that af-
fects both the forebrain and the face. The etiology of HPE
is very heterogeneous, with at least 12 different genetic
loci implicated. One of these, HPE2 (MIM 157170), was
mapped to chromosome 2p21. Subsequent analysis of
SIX3, an atypical homeobox gene, as a strong candidate
gene within the critical interval revealed four different
heterozygous point mutations that are predicted to inter-
fere with SIX3 transcriptional competence. Two further
patients with HPE were shown to carry translocation
breakpoints outside the SIX3 transcribed region; these
were located by pulsed-field gel electrophoresis at 10–200
kb upstream of the transcription initiation point (Wallis
et al. 1999).
HPE3 (MIM 142945) was defined as another HPE
locus and was associated with chromosome 7q36 dele-
tions, and eventually point mutations were identified
within the candidate gene sonic hedgehog (SHH). Phe-
notypic expressivity can vary, even within families—from
a single cerebral ventricle and cyclopia (lethal) to clinically
unaffected carriers, perhaps with a single central incisor
(Belloni et al. 1996; Roessler et al. 1996). Interestingly,
whereas HPE3 in humans is caused by haploinsufficiency
of SHH, in the mouse both alleles need to be inactivated
to produce a similar phenotype, which indicates a more
critical role for correct SHH dosage in humans (Chiang
et al. 1996). As for SIX3, balanced translocations with
breakpoints up to 265 kb 5′ of the SHH transcription
start site (Belloni et al. 1996; Roessler et al. 1996, 1997)
were documented in individuals with HPE. A further fa-
milial translocation, 315 kb upstream of the SHH start,
did not produce a detectable HPE phenotype in the seven
individuals examined, thus limiting the region in which
to look for the putative control element(s) (Roessler et al.
1997).
Distant Regulators for SHH Expression Are Also
Involved in Limb Development
As mentioned, the phenotype caused by a regulatory
mutation can be very different from that caused by cod-
ing-region mutations, because expression may only be af-
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fected in a subset of expressing tissues. The involvement
of SHH in preaxial polydactyly (PPD [MIM 174500]) fits
such a scenario. In addition to its many functions in brain
and neural development, SHH plays a key role in defining
the limb anterior-posterior axis. Normally, Shh is tran-
siently expressed in the posterior part of the mouse limb
bud and sets up a morphogen gradient from this zone of
polarizing activity (ZPA). PPD is associated with mirror-
image duplication of the hand/foot. One form is seen in
the mouse mutant Sasquatch (Ssq), which arose during
transgenic studies as a result of random insertion of a
reporter cassette 1 Mb upstream of the Shh gene (Sharpe
et al. 1999) (fig. 2C). None of the other independent trans-
gene insertion mice showed this phenotype, which sug-
gests that the Ssq phenotype is caused by the insertion of
the transgene into that specific site, which was revealed
by molecular analysis as intron 5 of the limb region 1
gene (Lmbr1) and which lies beyond the adjacent testis-
and ovary-specific gene Rnf32. Homozygous transgenic
mice have a more severe limb phenotype than heterozy-
gotes. Genetic analysis of two other mouse limb mutants,
Hemimelia extra-toes (Hx) and Hammertoe (Hm), also
mapped to Lmbr1 and the expression of this gene was
found to be altered in Hx embryos at the relevant time
in limb formation (Clark et al. 2000). However, the trans-
genic Ssq mice with PPD, as well as Hx and Hm mice
with the disease, all showed ectopic expression of Shh in
an anterior, as well as the normal posterior, region of the
limb bud (Sharpe et al. 1999; Lettice et al. 2002; Hill et
al. 2003). This explains the mirror-image duplication phe-
notype and suggests that the correct control of Shh ex-
pression in the limb bud is disrupted by the transgene
insertion (Lettice et al. 2002). To strengthen this conclu-
sion, a cis-trans test was performed, which showed that
when the Ssq transgene insertion (or the Hx mutant) is
recombined to work in cis with a functionally null Shh
allele, the PPD phenotype is abolished (Lettice et al. 2002;
Sagai et al. 2004). These results strongly suggested the
presence of a limb regulatory element for Shh expression
1 Mb upstream of the gene. By use of phylogenetic se-
quence comparison, an evolutionarily conserved sequence
that brackets the Ssq insertion site was identified, and
analysis in transgenic mice revealed reporter expression
in the posterior margin of the limb buds, which implies
that the isolated regulatory element, now designated as
the “ZRS” (ZPA regulatory sequence), can function as a
limb-specific enhancer (Lettice et al. 2003). The endoge-
nous ZRS is also predicted to harbor repressor function
in the anterior limb bud, since its disturbance leads to
ectopic Shh expression there.
A chromosomal breakpoint in a translocation-associ-
ated case of human PPD was mapped within the ho-
mologous intron of LMBR1 (Lettice et al. 2002). PPD is
a relatively frequent human phenotype, which had been
tightly linked in many families to the LMBR1 gene. In-
terestingly, in patients with the severe human recessive
limb anomaly acheiropodia (bilateral congenital ampu-
tations of the upper and lower extremities and aplasia of
the hands and feet), a deletion that apparently removes
exon 4 of LMBR1 was identified, and, initially, it was
suggested that LMBR1 itself plays a major role in the
disorder (Ianakiev et al. 2001). However, in light of the
evidence cited above, it seems more likely that the in-
volvement of LMBR1 is merely due to it harboring reg-
ulatory elements that control Shh expression in the limb.
To assess whether mutations in the ZRS could account
for the PPD phenotype in some affected families without
translocations or deletions, the element was sequenced in
a large number of affected and unaffected family members
and controls. Amazingly, single point mutations in the
ZRS were found in four families with PPD; these muta-
tions were observed in all of the affected and none of the
unaffected individuals in these families (Lettice et al.
2003). All four point mutations were in different parts of
the ZRS. Analysis of the ZRS in the Hx mouse and an
N-ethyl-N-nitrosourea–induced mutant, M100081, iden-
tified two more independent point mutations (Sagai et al.
2004). As mentioned, the ZRS is thought to have a dual
function in the regulation of SHH: (1) driving the initi-
ation of expression in the limb bud and (2) restricting this
expression to the posterior margin. The Ssq insertion and
the Hx, M100081, and PPD point mutations affect the
latter (but not the former) activity of the ZRS, which leads
to the observed anterior ectopic SHH expression.
This illustrates the remarkable fact that point muta-
tions in a regulatory element at a distance of 1 Mb from
the gene promoter can have a detrimental effect on de-
velopment. The scattered positioning of the mutations
within the element suggests that different transcription-
factor binding sites may be disrupted, with similar out-
comes. An interesting link with development and evo-
lution is that the ZRS is recognizably conserved in all
vertebrates with some sort of locomotory appendage
(limbs, wings, or fins), but it is absent in snakes and a
limbless newt (Lettice et al. 2003; Sagai et al. 2004).
Split-Hand/Split-Foot Malformation
To underscore our current ignorance of long-range reg-
ulatory mechanisms, we touch on another phenotype:
split-hand/split-foot malformation type 1 (SHFM1 [MIM
183600]), a heterogeneous limb developmental disorder
characterized by missing digits, fusion of remaining digits,
and a deep median cleft in the hands and feet—a phe-
notype that is almost certainly caused by a long-range
regulatory anomaly. The SHFM1 critical region has been
mapped to 7q21.3-q22.1, on the basis of chromosomal
rearrangements (Scherer et al. 1994; Crackower et al.
1996; Ignatius et al. 1996). Three genes, DSS1 and the
distalless homeobox genes DLX5 and DLX6, are located
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in this region, but none of these genes is directly inter-
rupted by the translocations and deletions. The absence
of patients with intragenic coding-region mutations has
so far prevented the clear designation of the SHFM1
gene(s) in humans. Targeted inactivation of either Dlx5
or Dlx6 alone does not produce a limb phenotype in
mouse (Robledo et al. 2002). However, the targeted dou-
ble inactivation of Dlx5 and Dlx6 causes bilateral ectro-
dactyly with a severe defect of the central ray of the hind
limbs, a malformation typical of SHFM1. Dss1 expres-
sion in these mice is normal. This raises the possibility
that SHFM1 is due to the disruption of a shared regu-
latory element for the two DLX genes and possibly DSS1
(Merlo et al. 2002).
Aberrant Gene Expression in Human Disease through
Altered Chromatin Structure
FSHD
FSHD (MIM 158900) is a neuromuscular disorder
affecting predominantly the facial and shoulder girdle
muscles. It is inherited as an autosomal dominant trait,
but ∼10%–30% of the mutations are de novo, and about
half of these are somatic mosaics. The molecular re-
arrangement associated with FSHD is the deletion of
an integral number of 3.3-kb tandem repeats from the
subtelomeric region of the long arm of chromosome 4
(Wijmenga et al. 1992). Unaffected individuals carry be-
tween 11 and 150 copies of this repeat (fig. 2D), named
D4Z4, whereas patients carry 10 copies on one of their
chromosomes (van Deutekom et al. 1993). In general,
the lower the number of D4Z4 repeats, the greater the
severity of the phenotype and the younger the age at
onset. The D4Z4 repeat contains internal VNTR-type
repeats and a putative ORF (DUX4), but no protein-
coding transcripts have been identified from the repeat
sequence, despite intense efforts. FSHD is therefore
thought to result from some form of cis interaction, be-
tween the shortened 4q35 repeat region and more-cen-
tromeric genes in the 4q35 region. This is supported by
the fact that an almost identical repeat array on chro-
mosome 10q26, with further homology on both sides
of the repeat, does not cause disease when shortened
(Bakker et al. 1995). A number of genes or putative
genes have been identified in the region centromeric
to the D4Z4 repeats on chromosome 4q35: FRG2,
DUX4C, FRG1, and ANT1. ANT1, the most centrom-
eric of these, located ∼5 Mb from the proximal repeat
boundary, is considered the most likely candidate be-
cause it encodes an adenine nucleotide translocator that
has been implicated in myopathy and is predominantly
expressed in heart and skeletal muscle (Gabellini et al.
2002). Interestingly, individuals with deletion of the en-
tire array, including D4Z4, FRG2, DUX4C, and FRG1,
show no phenotypic consequences (Tupler et al. 1996).
This suggests that the loss of repeats results in a gain-
of-function mutation, but much debate continues over
the mechanism. Recently, it was claimed that the D4Z4
repeats bind a multiprotein repressor complex that neg-
atively regulates expression of genes in the 4q35 region,
possibly through promoting a cis-spreading heterochro-
matinization of the region. In this model, D4Z4 deletions
would lower the number of binding sites for the re-
pressor complex below a critical threshold, thus allow-
ing local decondensation of chromatin and the conse-
quent derepression (up-regulation) of the genes in the
region (Gabellini et al. 2002). In support of this position-
effect hypothesis, one study found that all the genes in
the region were up-regulated in muscle from patients
with FSHD, and a protein complex that contained a
subunit with known repressor activity was isolated and
was shown to bind specifically to a site in the D4Z4
repeat (Gabellini et al. 2002). However, another recent
study found no difference in expression levels of ANT1
and FRG1 between muscle tissue of patients with FSHD
and unaffected individuals. Furthermore, histone H4
acetylation levels over the various gene promoters sug-
gested that the region adopts a nonexpressed euchro-
matinlike structure, both in control individuals and in
patients with FSHD (Jiang et al. 2003). Instead, a model
was proposed in which a short array of D4Z4 repeats
forms a long-distance loop that interacts directly with
an as-yet unknown gene or genes on 4q35 to increase
expression, whereas longer arrays of D4Z4 repeats form
intra-array loops and thus sequester the array (Jiang et
al. 2003). Recent work furthermore suggests that the 4q
telomere always localizes at the nuclear periphery, re-
quiring lamin A/C to do so. Although this specific lo-
calization is observed in both normal and D4Z4-deleted
alleles, FSHD is proposed to arise from improper inter-
actions with transcription factors or chromatin modifiers
at the nuclear envelope (Masny et al. 2004).
a-Thalassemia and Antisense RNA
A completely different type of mechanism was shown
to be responsible for a recently reported case of a-thal-
assemia (MIM 141800) (Tufarelli et al. 2003) (fig. 2E).
Thalassemias result from an imbalance in the levels of
the a- and b-globin chains that constitute the oxygen-
carrying hemoglobin tetramer in human red blood cells.
In general, this is caused by mutation or deletion of one
or more of the globin genes or, as in the case of the
Spanish and Dutch thalassemias, by the deletion of the
b-globin locus control region. The a-globin gene is nor-
mally transcribed from four major gene copies (HBA1
and HBA2, on each chromosome 16), under the control
of the 5′ HS-40 region. In the recently reported case of
a-thalassemia, an 18-kb deletion, encompassing the
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HBA1 and HBQ1 genes, was identified. The HBA2 gene
and HS-40 remained completely intact. One copy of the
HBA1 gene was deleted in this family, but the severity
of the phenotype suggested that expression from the in-
tact HBA2 gene on the deleted chromosome could also
be affected. The absence of HBA2 expression from the
abnormal chromosome was confirmed in an experiment
that used permissive cell hybrids. Subsequently, a 2-kb
region, including the HBA2 CpG island, was found to be
densely methylated in all tissues of this individual,
whereas under normal circumstances the a-globin CpG
islands always remain unmethylated, even in nonex-
pressing tissues. Further analysis of this mutation showed
that silencing and methylation of the HBA2 promoter
were strongly correlated with the presence of antisense
RNA transcripts derived from the truncated neighboring
LUC7L gene on the opposite strand (fig. 2E). In addition
to the HBA1 and HBQ genes, the 18-kb deletion had
removed the final three exons of the LUC7L gene, in-
cluding its polyadenylation signal, which caused the RNA
polymerase to read through into the HBA2 gene and pro-
moter. The silencing and methylation of the HBA2 pro-
moter, induced by the aberrant read-through transcription
of LUC7L, was confined to the deleted chromosome,
which indicates that it occurs through a cis-acting mech-
anism (Tufarelli et al. 2003).
This case presents a very different mutational mech-
anism that can result in turning off expression at a neigh-
boring locus. Although it does not involve disruption of
long-range gene control required for normal expression
of the gene, it does represent a mechanism that could
easily cause problems at many other gene loci, partic-
ularly in gene-dense regions of the genome. Other ex-
amples are likely to come to light when a highly ex-
pressed truncated gene lacking a polyA signal as a result
of deletion or translocation prevents expression of an
intact, adjacent disease gene (on the opposite strand) by
an aberrant read-through mechanism (fig. 2E).
Exploring Gene Regulation through Animal Models
The cases described above highlight genes in which long-
range transcriptional control has been identified through
the analysis of patients with genetic malformations. There
are, however, many more genes for which long-range gene
regulation undoubtedly plays an important role but for
which no position-effect–type mechanism of disease has
so far been shown (e.g., Di Leone et al. 2000; Hadchouel
et al. 2003). For some of these genes, long-range regu-
latory control has been explored through gene manipu-
lation—sometimes accidentally, in mouse gene knockouts
with unexpected outcomes (Olson et al. 1996). Associated
human (or mouse) mutant phenotypes may exist but will
not be readily identified if the phenotype is not caused by
haploinsufficiency. In other cases, the disruption may have
only a subtle effect or may give rise to a different phe-
notype from the one shown in the case of complete gene
inactivation and therefore would not readily be associated
with the gene of interest. Below, we describe three gene
loci for which studies in mouse and sheep have contrib-
uted to our understanding of long-range gene control.
Hoxd Cluster
An interacting gene complex in which long-range con-
trol has been studied extensively in the mouse is the Hoxd
cluster. The locus contains a number of genes, including
the Hoxd complex and the Evx2 and lunapark (Lnp)
genes, that are involved in patterning of the body axis in
the lumbosacral region, as well as in limb development
and the correct formation of the digits (Spitz et al. 2003).
Elegant studies of the cluster, with its characteristic colin-
earity in spatiotemporal expression of the genes correlat-
ing with gene order along the chromosome, have led to
the notion that the ancestral role of the cluster was the
specification of morphogenesis along the main body axis
and that, later in evolution, the Hoxd genes were co-opted
to function in the development of novel structures, such
as the limbs (Spitz et al. 2001). Consistent with this sce-
nario, it was shown that the regulatory controls for the
ancestral and colinear expression are located within the
Hoxd cluster, whereas the co-opted expression domains
depend on enhancers located at remote positions outside
the cluster (Spitz et al. 2001). During limb development,
Hoxd10–13 and the neighboring genes Evx2 and Lnp
(fig. 2F) are coexpressed, with very similar profiles, in
digits (Spitz et al. 2003), which suggests the possibility
that a single enhancer may control digit expression for
all these genes (van der Hoeven et al. 1996). A search for
such an enhancer through BAC transgenics and sequence
comparisons led to the identification of a region far up-
stream of the locus (fig. 2F) that controls tissue-specific
expression in multiple tissues of a contiguous set of genes
in the locus. This region, termed the “global control re-
gion” (GCR), is proposed to create a widespread regu-
latory landscape, sharing its enhancing activity over a
defined number of genes in a tissue-specific manner (Spitz
et al. 2003). Digit activity of the GCR spreads over six
genes that cover at least 240 kb, whereas CNS activity is
limited to the Lnp and Evx2 genes. A direct demonstra-
tion of the role of the GCR was provided by analysis of
a semidominant mouse limb mutant, Ulnaless (Herault et
al. 1997; Peichel et al. 1997). Ulnaless carries a paracentric
inversion with one breakpoint in the Lnp gene and the
other breakpoint 770 kb more telomeric; this inverts the
Evx2 and the Hoxd cluster and moves it ∼700 kb from
the remains of Lnp. When Ulnaless was bred against a
targeted allele with a deletion of the region from Evx2 to
Hoxd11, expression of Evx2 and Hoxd13 was shown to
be lost in the distal limb (Spitz et al. 2003). This suggests
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that the inversion either has moved the limb-expressed
genes out of reach of the GCR, or it has introduced some
insulating activity between the genes and the GCR. Evo-
lutionary sequence comparison of the human GCR region
revealed very strong sequence conservation over several
kb in mouse, as well as in two shorter regions in the teleost
fish F. rubripes. The latter has no digits or external gen-
italia and lacks the Hoxd1, Hoxd8, and Hoxd13 genes,
although Hoxd12, Evx2, and Lnp are present (Spitz et
al. 2003). Although no human cases of chromosomal dis-
ruptions between the GCR and the HOXD genes have
been described, a putative regulatory change has been
reported at the other (telomeric) end of the cluster. A
patient suffering from mesomelic dysplasia (shortening
of the forearms and forelegs) with vertebral defects was
found to carry a balanced translocation breakpoint 56 kb
telomeric of the HOXD1 gene (Spitz et al. 2002) near
MTX2.
Limb Deformity
Recent reassessment of a much-studied mouse recessive
mutant, limb deformity (ld), has revealed that the original
assignment of the phenotype to loss of function of the
disrupted formin gene (Fmn) was incorrect. Three ld al-
leles were clearly shown, some time ago, to truncate Fmn
(Maas et al. 1990; Wang et al. 1997). However, the out-
of-frame deletion of exon 10 in the large Fmn gene fails
to produce limb deformity, although a larger deletion
from exon 10 to exon 24 does recapitulate the ld phe-
notype. Two previously uncharacterized ld alleles have
now been shown to disrupt the neighboring gene gremlin
(Grem1), and Grem1-targeted knockout mice are allelic
with ld (Michos et al. 2004; Zuniga et al. 2004). Gremlin
is a cystine knot protein that functions as a bone mor-
phogenic protein (BMP) antagonist and that is itself reg-
ulated by SHH. Further investigation reveals that the re-
gion from exon 19 to exon 23 of Fmn is the site of a
GCR required for GREM1 expression in the limb and
that this region is responsive to SHH signaling. This is
therefore an example in which, for over a decade, the
wrong gene was implicated in a developmental anomaly
because several alleles caused disruption of the gene that
houses a major regulatory element for the real culprit,
Grem1. The alleles that disrupt Grem1 directly have a
more severe homozygous phenotype than the Fmn-dis-
rupting alleles. The Grem1/ mice have complete renal
agenesis and lung septation defects, in addition to the limb
anomaly. It will be interesting to see whether GREM1
mutations will be found in appropriate human limb/kid-
ney phenotypes, possibly only in populations with fre-
quent consanguinity. This is also a salutary example of
how readily we can be misled into associating disease
pathology with the wrong gene when mutations disrupt
a neighboring, functionally unrelated gene that harbors
cis elements controlling the real culprit.
Callipyge (CLPG) Mutation in Sheep
A striking example of the effect of a single-nucleotide
substitution in a putative long-range regulatory element
is provided by the CLPG mutation in the imprinted re-
gion DLK1–GTL2 of sheep (Georges et al. 2003). The
callipyge (CLPG [“beautiful buttocks”]) phenotype is
characterized by hindquarter muscle overgrowth that
only affects heterozygotes with paternal inheritance of
the CLPG mutation (Cockett et al. 1996). The compli-
cated mechanism behind CLPG, termed “polar over-
dominance,” is thought to be a combination of a direct
long-range cis-regulatory effect on transcription of the
genes in the region and a transinteraction with a tightly
linked transacting repressor. The CLPG region contains
two paternally expressed protein-encoding genes, DLK1
and PEG11, and two maternally expressed noncoding
genes, GTL2 and MEG8. All four genes show a post-
natal increase in muscle-specific expression, when linked
in cis to the CLPG mutation, while maintaining their
imprinted status. By use of DNA from the mutants and
from the mosaic founder individual, the CLPG mutation
was identified as a single-base substitution in a region
of strong sequence conservation 33 kb upstream of the
GTL2 gene (Freking et al. 2002). In the current model,
the paternally expressed DLK1 or PEG11 is proposed
to encode an effector for muscle growth, whereas either
of the maternally expressed GTL2 and MEG8 noncod-
ing RNAs could act as a repressor. Only when the CLPG
regulatory mutant allele is paternally inherited would
there be an overexpression of the effector without the
concomitant up-regulation of the repressor (Georges et
al. 2003).
Identifying Novel Distant Regulatory Elements
Even quite recently, tissue-specific regulatory elements
were generally identified by promoter/enhancer deletion
studies in transgenic mice (Pfeffer et al. 2002) or by DNase
I hypersensitivity mapping in expressing tissues (Elgin
1988; Kleinjan et al. 2001). The latter technique is based
on the observation that local disruptions of the regular
nucleosomal array create preferential targets for DNase
I at low concentrations of the enzyme. Binding of tran-
scription factors to the DNA at cis-regulatory elements is
thought to cause the removal or dispersal of a nucleosome.
Thus DNase I HSs are often found at active cis-regulatory
elements. Genomic regions close to the promoter are
sometimes further explored by footprinting and by elec-
trophoretic mobility-shift assays, which seek to identify
regulatory protein-binding DNA regions (Knight 2003).
With the explosion of genomic sequences available for
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many model organisms, multiple sequence comparisons
between evolutionarily diverged species have revealed
many highly conserved genomic regions outside coding
domains (Dubchak and Frazer 2003). The conservation
of these sequences is taken to imply functional signifi-
cance, most likely in gene regulation (Hardison 2000;
Pennacchio and Rubin 2001). Indeed, a high proportion
of regulatory elements that were previously validated—
for example, by transgenic reporter studies—were found
to be highly conserved, often across several vertebrate
classes. Conversely, sequence conservation is now often
the starting point for functional studies to reveal regu-
latory properties in novel transgenic and gene-targeting
studies (Williams et al. 1998; Griffin et al. 2002; Nobrega
et al. 2003; Uchikawa et al. 2003; Kimura-Yoshida et al.
2004; Kleinjan et al. 2004).
A conserved element was identified by cross-species
sequence comparison in the intergenic space between
the Il4 and Il13 cytokine genes (Loots et al. 2000).
Targeted deletion in mice revealed it to be a coordinate
enhancer for Il4 and Il13, as well as for the more distant
Il5 gene; this deletion influences gene expression in TH2
cells and leaves expression in mast cells unaltered. Two
other genes in the region—Kif3a, upstream of Il4, and
Rad50, located between Il13 and Il5—were shown to
be unaffected by the enhancer (Loots et al. 2000; Mohrs
et al. 2001) (fig. 2G).
In most cases, functional analysis of conserved ele-
ments has been through the generation of transient or
permanent transgenic reporter animals, which are pro-
duced to show that the reporter expression pattern mir-
rors a subset of the expression spectrum shown by the
endogenous gene (Kleinjan et al. 2001; Griffin et al. 2002;
Nobrega et al. 2003). Some of these analyses have now
become quite systematic: large flanking regions around
genes that are known to require complex spatiotemporal
expression for full function have been screened. Selection
of a distant species for comparison can help focus on the
major functionally conserved elements, as shown by the
comparison of mouse and chick Sox2 (Uchikawa et al.
2003). Use of the more compact F. rubripes genomic
sequence for comparison means that a larger region of
the genome can be surveyed, which is useful for genes
like Otx2 and others with a very large regulatory domain
(Kimura-Yoshida et al. 2004). This new capacity to iden-
tify regulatory elements more readily through evolution-
ary sequence comparison will allow the development of
methods to identify and validate functionally significant
variants and pathologic mutations in these regions.
Long-Range Regulation: Common Theme or Selected
Few?
It is intriguing to note that most genes in which distur-
bance of long-range control has been observed are key
developmental regulators. The examples above mainly in-
volve tissue-restricted transcription factors that directly or
indirectly bind to DNA. The remainder are developmental
signaling molecules such as SHH. All of these genes play
multiple recurrent roles in the determination, patterning,
and differentiation of many tissues and organs—they are
frequently reused at different stages of development (even
within a single tissue), sometimes in collaboration with
different partner proteins. For example, PAX6 and SOX2
are implicated in early lens determination and also later
differentiation (Treisman and Lang 2002), and both are
also differentially expressed in the retina and the brain
(van Heyningen and Williamson 2002). To fulfill these
multiple roles, they require complex spatiotemporal ex-
pression control, which evolves through phylogenetic di-
versification (see below).
From a regulatory viewpoint, genes can be grouped
broadly into three classes: (1) “Housekeeping” genes,
which are required for the functioning of most or all cells
and therefore generally ubiquitously expressed; these
genes usually have promoters that are active in all cells
without the need for specific enhancer elements. (2) Tis-
sue-specific genes, which play a specific role in the par-
ticular function of the differentiated cell-type; these genes
are usually regulated through one or a few specific en-
hancers. (3) Developmental regulator genes, which func-
tion in specific tissues at defined time-points in devel-
opment—sometimes at critically defined levels—and
have to be strictly inactive in all other tissues and time-
points; to achieve such sophisticated expression profiles,
these genes require multiple enhancer elements that all
need to be fitted into the cis region surrounding the gene.
Despite the common use of terminology, which suggests
some sort of engineered design in the structure of gene
loci with respect to transcription and other biological
processes, the acquisition and loss of regulatory elements
does not occur through conscious design but rather as a
result of evolutionary tinkering and selection (Duboule
and Wilkins 1998; Carroll et al. 2001). The redeployment
of developmental regulatory genes in novel tissues and
pathways has become a recognized feature in the evo-
lution of greater complexity in higher organisms. To a
large extent, this depends on the chance appearance of
a new combination of sequences with regulatory activity
in the vicinity of the appropriate promoter. As long as
the element can establish interaction with the promoter,
does not interfere with the existing regulatory control in
a disadvantageous manner, and presents some kind of
evolutionary advantage itself, the new cis element may
become fixed. The further appearance of elements sy-
nergizing with existing ones to achieve the optimal ex-
pression level more reliably will similarly confer selective
advantage and retention. Interestingly, in some cases in
which there is evidence of the redeployment of regulatory
factors in more recent evolutionary adaptations, a cor-
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relation often exists between the more proximal location
of enhancers involved in the ancestral function of the
gene and the more distal position of regulatory elements
required for more recently co-opted expression in novel
tissues, as described above for the Hoxd cluster.
Evolution of Regulatory Control
Gain and Loss of Elements
The increase in complexity from yeast to mammals is
not adequately reflected in expanded gene numbers. The
emerging view is that the growth in evolutionary com-
plexity is predominantly brought about by increasing reg-
ulatory intricacy (Carroll et al. 2001; Levine and Tjian
2003) and that a significant component of this is through
alterations in cis regulation (Wray et al. 2003; Howard
and Davidson 2004). New cis-regulatory elements can
arise by several mechanisms, including random sequence
mutation and genomic insertions (for example, through
retrotransposition) (Han et al. 2004). These elements can
bring, from elsewhere in the genome, functionally active
sequences with regulatory capacity novel to the host gene.
On the other hand, transposon insertion can also be high-
ly deleterious and can cause disease (Druker and White-
law 2004). Another frequently observed mechanism for
acquiring novel function is through gene duplication fol-
lowed by divergence, not only of coding regions but even
more readily in regulatory domains. Gene duplications
may arise locally by aberrant recombination or replication
(Hurles 2004) and may encompass one or a few adjacent
genes. Occasionally, chromosome or genomewide dupli-
cations take place, generally followed by loss of many of
the duplicated segments, as in teleost fishes (Robinson-
Rechavi et al. 2001). There is ample evidence of all these
types of events in most organisms. Phenotypic changes
can also arise through loss of cis elements associated with
a particular gene, as exemplified by the pelvic reduction
seen in threespine sticklebacks (Shapiro et al. 2004).
Genomic Organization
Some developmental regulator genes with a network of
multiple elements to control their intricate spatiotemporal
expression pattern have a relatively simple genomic or-
ganization: they reside in regions that have been termed
“gene deserts” (Nobrega et al. 2003). The regulatory do-
mains of DACH (Nobrega et al. 2003; Boffelli et al. 2004)
and SOX9 (Pfeifer et al. 1999) apparently cover 1 Mb
or more of genomic sequence, with no other recognizable
genes in the vicinity. For many genes, the situation is much
more complex. A strange consequence of the complex
genomic movements and rearrangements associated with
the ongoing evolution of regulatory functions is that cis
elements for one gene are quite often embedded within
another nearby gene, generally within its introns. The
neighboring genes usually fulfill very different functions—
for example, highly tissue-specific genes may have regu-
latory elements embedded in ubiquitously or differently
expressed genes (Bennani-Baiti et al. 1998; Kleinjan et al.
2002; Lettice et al. 2002; Zuniga et al. 2004). This type
of functional link between otherwise apparently unrelated
genes can provide a mechanism underlying conservation
of synteny across classes (Kleinjan et al. 2002; Santagati
et al. 2003).
Mechanisms of Long-Range Regulation
Structural Versus Functional Domains: Hypotheses
In the context of such complexity and diversity of ge-
nomic organization, it is difficult to develop a unified
model for regulatory function. To explain how genes
maintain their independence, the concept of “structural
gene domains” has been widely discussed for many years.
However, this model is largely based on the analysis of a
small number of intensely studied gene loci. In the struc-
tural domain model, genes enjoy functional autonomy
through physical separation from neighboring domains
by specific sequences (Dillon and Sabbattini 2000). Ad-
jacent structural domains would be distinguished by dif-
ferences in their local chromatin structure, with transcrip-
tionally active domains displaying an “open” chromatin
structure, whereas neighboring inactive domains would
have “closed” compacted chromatin. In this model, an
important role is played by the boundary, or insulator,
elements—sequences that function specifically to prevent
the spread of active or inactive chromatin from one do-
main into the next. Strong support for the concept of
structural domains was provided by the intensely studied
relationship between chromatin structure and gene acti-
vation at loci such as the chicken b-globin locus (Prioleau
et al. 1999). These studies have, indeed, led to the iden-
tification of such insulator elements at the borders of do-
mains. Insulator elements are defined as sequences with
the capacity to block enhancer-promoter interactionwhen
placed between the two element types in certain assays;
they can also insulate a flanking reporter cassette from
repressive chromatin at the site of integration in transgenic
assays (Bell et al. 2001; Burgess-Beusse et al. 2002). How-
ever, the finding that independently regulated loci can par-
tially or completely overlap and that their cis-regulatory
elements can be found within or beyond neighboring un-
related genes puts the universal applicability of the struc-
tural domain model into question.
Direct evidence for the structural domain model is al-
ready somewhat less convincing in the human b-globin
locus, and it is clear that it does not apply to the a-
globin locus. The a- and b-globin domains probably
arose by duplication of a single ancestral gene. In con-
trast to the b-globin gene cluster, the a-globin gene is
located in a large region of “open” chromatin that con-
tains a number of housekeeping genes (Flint et al. 2001).
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Figure 3 Model for the coexistence of physically overlapping but independently regulated “functional gene expression modules” in the
same genomic region. A hypothetical region containing two tissue-specific genes and one housekeeping gene. Gene X (blue exons) is expressed
in eye tissue, gene Y (purple exons) is expressed in brain, and gene Z (green exons) is ubiquitously expressed. Transcriptional activity depends
on the formation of an ACH that encompasses tissue-specific cis-acting elements with bound transcription factor complexes and selective
interaction with the relevant gene promoter. Formation of an ACH provides a high local concentration of transcription factors and positive
chromatin-modifying enzymes. The housekeeping promoter is active in all cells and does not rely on tissue-specific ACH formation.
In common with some of the disease genes described
above, the main critical regulatory element of the a-
globin locus, the 40-kb enhancer, is located within an
intron of a neighboring, ubiquitously expressed house-
keeping gene (Vyas et al. 1995). In the case of PAX6, a
number of regulatory elements are spread throughout at
least three introns of the neighboring ELP4 gene (Klein-
jan et al. 2001). In the human growth hormone cluster,
elements required for tissue-specific expression of the
pituitary-specific GHN gene and the placenta-specific
CSL, CSA, GHV, and CSB genes are located beyond a
B-cell–specific gene (CD79B), within introns of the mus-
cle-specific SCN4A gene (Bennani-Baiti et al. 1998). In
this case, this genomic organization has led to the for-
tuitous activation of CD79B in the pituitary, where it
has no known function, as a result of a bystander effect
(Cajiao et al. 2004). This challenges the common as-
sumption that specific high-level expression in a partic-
ular tissue implies a function for the gene in that tissue.
Additional examples are provided by other cases de-
scribed above. These observations provide compelling
arguments against a fundamental requirement for the
physical isolation of a gene and its regulatory sequences.
Rather it has been proposed that specificity of enhancer-
promoter interactions (fig. 3) is the key to maintaining
functional autonomy of adjacent genes (Dillon and Sab-
battini 2000). Viewed in the light of evolution, tran-
scriptional control elements and chromatin structure at
a locus will have coevolved under positive and negative
selection to form the gene domains we observe today.
In instances such as the b-globin locus, this will have
led to domains that are structurally isolated from their
surroundings, whereas, in many other cases, including
a-globin, a large, integrated gene region without distinct
boundaries has emerged. Although the concept of a gene
as a physical entity, with a distinct map position on the
chromosome, is still useful in many instances, a new
model has been proposed that is based on the old defi-
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nition of the gene as a “unit of inheritance” (Dillon 2003).
Here, genes are defined in functional terms as “functional
expression modules” that encompass both the transcribed
regions and their cis-regulatory control systems and that
function appropriately in different cells types (fig. 3)
within the context of the local chromatin architecture.
Setting Up Models
Participation of a promoter is essential for transcrip-
tion. Spatiotemporal and quantitative regulation of gene
expression is brought about through the influence of cis-
regulatory elements, such as enhancers and repressors.
Since the first demonstration of the existence of distant
enhancers, one of the main questions has been how these
elements communicate regulatory activity to their target
promoters over such large spans of intervening DNA. This
question has been studied most extensively at the b-globin
locus. Spurred by the original observations of gb-thal-
assemias in patients with deletions of a distant upstream
regulatory region (the locus control region [LCR]), but
with intact promoters and globin transcription units (fig.
2H) (Kioussis et al. 1983; Driscoll et al. 1989), the globin
locus been used extensively to explore how the LCR may
work to drive high-level expression of the globin genes
in erythroid cells (Fraser and Grosveld 1998). The model
that is most commonly encountered in the context of en-
hancer-promoter interactions is the “looping” model; in
this model, transcription factors bound at the enhancer
make direct contact with the promoter and/or with factors
bound at the promoter, while the intervening DNA loops
out (Bulger and Groudine 1999). In the favored “random
collision” model, both the enhancer and the promoter
initially move around at random until they encounter each
other, whereupon contact is established, which leads to
activation of transcription. Other models differ from this
mainly in the way the enhancer-bound factors establish
contact with the promoter. In the “tracking” model, the
initially formed enhancer-bound complex actively scans
along the DNA in search of a promoter. In the “linking”
model, a chain of proteins/complexes extends from the
enhancer along the chromatin fiber to the promoter, where
it subsequently mediates gene activation. Combinations
of the tracking and looping models have also been pro-
posed, in which the complex tracking along the DNA
remains attached to the enhancer, dragging it along to
create a loop. In another model, the distant enhancer pro-
vides a nucleation site from which a signal, distinct from
the enhancer-bound factors, is transmitted along the chro-
matin fiber to the promoter. The existence of RNA tran-
scripts that originate from active enhancers at some loci
is intriguing and suggests a possible role for transcription
itself in chromatin modification of actively transcribed
regions (Gribnau et al. 2000; Kim and Dean 2004).
Visualizing Enhancer-Promoter Interaction
Two novel techniques provide strong support for a
mechanism of long-range interaction that involves close
contact between the enhancer and the promoter, as in the
looping model. Chromosome conformation capture (3C)
takes native chromatin from appropriate gene-expressing
tissue and uses formaldehyde to crosslink adjacent pro-
teins and DNA (Tolhuis et al. 2002). The DNA fiber is
then chopped up by restriction-enzyme digestion, fol-
lowed by religation under dilute conditions, such that
crosslinked restriction fragments will become preferen-
tially ligated to each other (intramolecular reaction), com-
pared with ligation of random fragments. PCRs with one
fixed primer (e.g., near the promoter) and a selection of
second primers from potential enhancers and from inter-
vening fragments throughout the locus are used to detect
specific chromatin interactions. The relative abundance of
PCR products obtained from distinct primer combina-
tions is considered proportional to the interaction fre-
quency between the chromatin segments they represent.
With the use of this information, models for cis interac-
tions can be developed. In a second assay—RNA-TRAP
(tagging and recovery of associated proteins)—a clever
combination of in situ hybridization and chromatin im-
munoprecipitation is used, again in expressing cells. An
intron-specific probe for the gene of interest, which has
been labeled with digoxygenin, is hybridized to specific,
nascent pre-mRNA transcripts in formaldehyde-fixed
nuclei. Next, antidigoxygenin antibodies conjugated to
horseradish peroxidase are introduced to target peroxi-
dase activity to the site of transcription. This activity pro-
duces free radicals that catalyze the covalent binding of
the biotin tag to nearby proteins. Chromatin fragments
tagged with biotin are then purified on streptavidin-
agarose columns, and the relative enrichment of a spe-
cific DNA fragment (detected by PCR) indicates that
the tagged sequence was in the vicinity of the nascent
mRNA and, by extrapolation, of the promoter (Carter
et al. 2002).
3-D Clustering of Active Cis Elements
Both techniques were applied to the endogenous mouse
b-globin locus, which is organizationally very similar to
the human locus shown in figure 2H. The murine cluster,
which spans ∼130 kb, consists of the LCR with six DNase
I HSs (5′r3′: HS6–HS1) and the four structural globin
loci, each with its own promoter (g and bh1 expressed
at embryonic stages and the adult bmajor and bminor
genes). There is an additional pair of HSs at around 60
kb upstream of g and another site, 3′ HS1, downstream
of bminor. The whole cluster is embedded in a large cluster
of olfactory receptor (OR) genes (Bulger et al. 1999).
Detailed analysis of the RNA-TRAP and 3C data has
not only shown a close interaction between the LCR and
Kleinjan and van Heyningen: Long-Range Gene Regulation 25
the globin gene promoters, but the data also suggest that,
in b-globin-expressing cells, the whole cluster adopts a
distinct conformation, with all HSs (including the active
bmajor and bminor promoters) being clustered together.
The inactive g and bh1 globin genes, as well as the silent
OR genes, loop out and do not participate in this clus-
tering. In nonexpressing brain cells, no specific close in-
teractions are observed: the locus seems to remain in a
linear conformation (Tolhuis et al. 2002). To describe the
spatial clustering of regulatory elements and active pro-
moters, the term “active chromatin hub” (ACH) was
coined. The successful setting up of an ACH was proposed
to be the key event required for the establishment of a
“functional expression module” (de Laat and Grosveld
2003). The result of ACH formation is a high-density
clustering of regulatory elements, their cognate-binding
factors, associated coactivators, and chromatin modifiers,
which sets up a suitable local environment to generate
precisely the required expression level. Depending on the
nature of its sequence and the bound recognition factors,
promoters and other regulatory elements may or may not
compete for interaction with the ACH. So far, the use of
the 3C and RNA-TRAP techniques has focused on the b-
globin locus, and much work remains to confirm and
validate the ACH model at other loci. However, the model
provides a compelling explanation for how overlapping
genes can be independently regulated and expressed. It is
well known that some enhancers display strong specificity
in their preference for certain promoter types over others.
Conversely, this could be interpreted as a differential af-
finity of the promoters of adjacent genes for a specific
ACH. Elegant experiments in Drosophila, for instance,
have shown that the AE1 enhancer from the Drosophila
Antennapedia gene complex (ANT-C) and the IAB5 en-
hancer from the Bithorax complex (BX-C) preferentially
activate TATA-containing promoters when located equi-
distant from a TATA-containing and a TATA-less pro-
moter (Ohtsuki et al. 1998). Promoter affinity may be
specifically enhanced by the presence of a so-called pro-
moter-proximal tethering element. Such a novel type of
element has been implicated in the regulation of the sex
combs reducedgene (Scr) in the Drosophila ANT-C. A
second enhancer in this complex, the T1 enhancer, by-
passes its neighboring fushi tarazu gene (ftz) and interacts
with the distant Scr promoter to activate expression in
posterior head segments. The tethering element is a 450-
bp promoter-proximal sequence that is essential for T1-
Scr interactions (Calhoun et al. 2002). Apart from pro-
moter selectivity (see also Hochheimer and Tjian 2003),
distance between enhancer and promoter on the linear
DNA fiber must play a role, since regulatory elements
need to be in cis to the gene they activate (barring some
poorly understood phenomena such as transvection). The
linear distance between enhancer and promoter is very
large in some cases (e.g., SHH and the limb enhancer
ZRS); nevertheless, the distance is presumably not unlim-
ited. On the other hand, in some multigene loci where
competition for interaction with a shared enhancer plays
a role, as in the globin gene and Hox clusters, distance
is a distinct factor, with proximal genes more likely to be
activated than more distant ones (Dillon et al. 1997).
Facilitators of Long-Range Interactions
Although the 3C (and, to some extent, the RNA-
TRAP) assays show the clustering of cis-regulatory ele-
ments and promoters in nuclear space in an ACH, these
techniques do not reveal the mechanism by which an ACH
is set up in the first place. Whether the loops are formed
through “random collision,” “looping and tracking,” or
some other mechanism remains an open question. The-
oretical calculations suggest that a process that depends
on random collision alone would be highly inefficient
when distances of more than a few kilobases are involved
(Rippe 2001). A class of proteins implicated in promoting
contact between promoters and distal enhancers is that
of “facilitator proteins,” exemplified by the Nipped-B and
Chip proteins originally identified in Drosophila (Dorsett
1999). CHIP, a LIM-domain–binding protein, was shown
to facilitate the activation of multiple genes by interacting
with diverse DNA binding proteins—for example, by pro-
moting the cooperative binding of homeobox factors to
DNA. Nipped-B, on the basis of its homology with yeast
sister chromatid cohesion protein SCC2, was suggested
to play a dual role. The more ancient function of facil-
itating transinteractions between sequences on sister chro-
matids has been adapted to include an additional role in
long-range transcriptional regulation (Rollins et al. 2004).
Recently, the human homologue of Nipped-B, NIPBL,
was identified as the gene mutated in individuals with
Cornelia de Lange syndrome (CDLS [MIM 122470])
(Krantz et al. 2004; Tonkin et al. 2004). CDLS is a mul-
tiple malformation disorder that is characterized by facial
dysmorphology, mental retardation, growth delay, and
limb reduction. In keeping with the putative general role
of NIPBL in facilitating long-range regulation of multiple
genes, dysregulation of several developmental control
genes may underlie the diverse phenotypic anomalies seen
in CDLS.
Regulatory Mutations and Variation in Human
Disease
This review aimed to emphasize that, although disease-
associated genetic changes are commonly thought of as
affecting the coding regions of genes, some may exert
their effect through abnormal gene expression that re-
sults from mutations that disturb the normal processes
of control. Transcriptional regulation is exerted through
interactions between cis-regulatory elements associated
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with a gene and through the chromatin structure of the
gene locus. Disruption of either of these may lead to
disease. The PAX6 and SHH position-effect cases are
good examples of the disruption of cis-regulatory ele-
ments; FSHD cases and the a-thalassemia case described
by Tufarelli et al. (2003) may be caused by aberrant
long- or short-range chromatin structure. Chromatin
changes are certainly known to be associated with dis-
eases of imprinting (Walter and Paulsen 2003) and also,
in many cases, with malignancy (Cho et al. 2004; Egger
et al. 2004). Cytological or molecular detection of these
changes is a component of molecular diagnostic tech-
nology, particularly in cancer. Advances in this type of
technology may lead to improved diagnostic capacity in
other disease-associated regulatory changes. The excit-
ing prospect of modulating gene expression through the
therapeutic alteration of epigenetic state is actively being
explored (Egger et al. 2004). Other diseases that exert
their effect through altered regulation of chromatin con-
formation are those associated with mutations in genes
with a role in chromatin modification (see the recent
review by Bickmore and van der Maarel [2003]).
The most obvious cases of transcriptional misregula-
tion as the cause of genetic disease are associated with
visible chromosomal rearrangements. However, as illus-
trated by many cases cited above, interpretation of what
gene is implicated can be difficult, since the disruption
may lie entirely in one gene while affecting expression of
a nearby gene. Furthermore, the phenotypes observed
may be very different from those that may be elicited by
coding-region changes in the causative gene. An even
more daunting task is the identification of small deletions
or mutations in cis elements, as exemplified by the case
of PPD and sonic hedgehog in which a single-nucleotide
substitution located 1 Mb from the causative gene pro-
duces a severe genetic defect (Lettice et al. 2003). An
emerging area of research aims to address this task
through the implementation of mutation-screening tech-
nology by genomic array hybridization, which may iden-
tify cryptic disease-associated deletions (Shaw-Smith et
al. 2004). To facilitate the detection of alterations that
specifically involve cis-regulatory regions, arrays carrying
the potentially relevant genomic elements can be pro-
duced after their identification in multispecies sequence
comparisons (Dubchak and Frazer 2003).
By far the largest category of as-yet poorly explored
regulatory variation will involve subtle sequence changes
in regulatory elements, which may alter the expression
pattern or level of the cognate gene, sometimes without
immediate or clearly recognizable effect. There is already
good evidence from several studies that, in cases in which
alleles can be distinguished, there is high-frequency her-
itable variation in the level of expression from different
alleles, as a result of polymorphisms at cis-regulatory
sites. Such variation may represent a significant propor-
tion of disease-associated QTLs. Data supporting this
notion have been gathered in mouse strains (Cowles et
al. 2002), as well as in humans (Yan et al. 2002; Knight
2004; Pastinen et al. 2004). Elegant evidence for evolu-
tionary change that arises through this pathway comes
from Drosophila studies (Wittkopp et al. 2004). Ex-
amples of regulatory QTLs associated with human var-
iations are beginning to be elucidated. One of the first
to be identified was the ancient polymorphism for lactase
persistence (MIM 223100) (Enattah et al. 2002), which
allows a high proportion of adults in European popu-
lations to digest milk. Two single-nucleotide variants in
cis-regulatory elements, located 13.9 kb and 22 kb up-
stream of the lactase gene promoter, are strongly cor-
related with continued high-level expression of lactase
(Olds and Sibley 2003).
In this postgenome era, we are just beginning to un-
derstand how long-range organization of the genome is
related to function. The detailed analysis of human ge-
netic malformations has proved to be invaluable—first,
in highlighting the occurrence and scope of long-dis-
tance transcriptional regulation in the genome, and sec-
ond, in the elucidation of some of the plethora of dif-
ferent mechanisms for long-range gene control. It seems
likely that complex transcriptional control is essential
for a substantial subset of all genes. The genes and dis-
eases discussed here form a small sample of that group.
They have shown us, however, that—despite the ever-
increasing technical advances in high-throughput tech-
niques—the laborious identification of the disease loci
and regulatory mechanisms involved in currently “un-
solved” human disorders remains a huge but rewarding
task.
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